Development of Piperazine- and Oxazine-Linked Pyrimidines as p65 Subunit Binders of NF–κB in Human Breast Cancer Cells
Nuclear factor kappa B (NF–κB) is a potential therapeutic target in breast cancer. In the current study, a new class of oxazine– and piperazine–linked pyrimidines was developed as inhibitors of NF–κB, overcoming the complexity of the oxazine structure found in nature and enabling synthesis under lab...
שמור ב:
| Principais autores: | , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI AG
2023-10-01
|
| סדרה: | Biomedicines |
| נושאים: | |
| גישה מקוונת: | https://www.mdpi.com/2227-9059/11/10/2716 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
